Steroid Treatment Focused Management of Graves’ Ophthalmopathy
Acta Medica BulgaricaGraves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H. +5 more
doaj +1 more source
Targeted immunotherapies for Graves’ thyroidal & orbital diseases
Frontiers in ImmunologyBackgroundGraves’ hyperthyroidism and its associated Graves’ orbitopathy are common autoimmune disorders associated with significant adverse health impact.
Alan Chun Hong Lee, George J. Kahaly
doaj +1 more source
Sirolimus (rapamycin) for the targeted treatment of the fibrotic sequelae of Graves’ orbitopathy [PDF]
, 2019 Jonathan C. P. Roos, Rachna Murthy
openalex +1 more source
Atypical Asymmetric Presentation of Severe Graves’ Orbitopathy [PDF]
, 2023 Priyanka Gupta +3 more
openalex +1 more source
Graves’ disease – management of Graves’ orbitopathy and thyrotoxicosis, including new therapies
, 2023 Agata Toboła +1 more
openalex +2 more sources
Association between lipid profiles and Graves orbitopathy: A systematic review and meta analysis
Endocrine and Metabolic ScienceIntroduction: Graves orbitopathy (GO) is an autoimmune disorder affecting the tissues around the eyes, seen in 25–50 % of individuals with Graves disease (GD).
Nanny Natalia Mulyani Soetedjo +5 more
doaj +1 more source
Severe Thyroid-associated Ophtalmopathy and Hashimoto´s Thyroiditis in Euthyroid Patient [PDF]
, 2016 info:eu-repo/semantics ...
Agapito, A +2 more
core
The incidence of diplopia following coronal and translid orbital decompression in Graves' orbitopathy [PDF]
, 1998 Dion Paridaens +3 more
openalex +1 more source
Immune reconstitution after alemtuzumab therapy for multiple sclerosis triggering Graves’ orbitopathy: a case series [PDF]
, 2018 Jonathan C. P. Roos +5 more
openalex +1 more source
Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy [PDF]
, 2021 Augustine George +3 more
openalex +1 more source